Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05739253

Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement

Status
Recruiting
Phase
Study type
Observational
Enrollment
480 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to assess the changes of ascending aortic diameter in patients undergoing transcatheter aortic valve replacement. The main questions it aims to answer are: 1. whether the ascending aortic diameter increases or remains stable after transcatheter aortic valve replacement, especially in patients with preoperative ascending aortic dilatation; 2. the determinants of postoperative ascending aortic dilatation.

Detailed description

Ascending aortic (AA) dilatation occurs frequently in patients with aortic stenosis (AS). For patients who are candidates for transcatheter aortic valve replacement (TAVR), simultaneous repair of a dilatated AA is technically difficult. As the indications for TAVR have extended to low-risk patients and patients with bicuspid aortic valve , AA dilatation should be considered as a new criterion to refine risk stratification in patients undergoing TAVR. In this observational study, we aim to evaluate the changes of AA diameters and identify the determinants post-TAVR AA dilatation.

Conditions

Interventions

TypeNameDescription
PROCEDURETranscatheter aortic valve replacementAll patients undergo transfemoral transcatheter aortic valve replacement for aortic stenosis

Timeline

Start date
2022-03-22
Primary completion
2025-03-21
Completion
2025-03-21
First posted
2023-02-22
Last updated
2025-02-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05739253. Inclusion in this directory is not an endorsement.